Srini Pharmaceuticals Limited

Company Description

Srini is a US-FDA and TGA approved pharmaceutical company located near Hyderabad, South India. Srini Pharmaceuticals Limited at Srini are actively engaged in the exports of Active Pharmaceutical Ingredients (APIs) and (N-1) drug intermediates to Regulatory and Non-Regulatory markets.

The facility has five full-fledged production blocks with the efficient utilities such as steam, chilled water, nitrogen generation, cooling water, vacuum and compressed air supply. It has state-of-the-art centralized quality control and R&D Lab.

The total capacity of the plant is 276 KL with Ten independent class 100,000 clean room areas to produce 360MT of APIs and 640MT of Intermediates per annum.

Company Information

Contact Person:Ms. Neelima Devi
Department:Marketing
Job Title:Business Development Executive
Telephone:
Fax:
Zip:500096
Province/State:Andhra Pradesh
City:Hyderabad
Business Type:Manufacturer
Year Established:1995
Number Of Employees:501 - 1000 People
Trade Capacity:North America : 9.09% South America : 9.09%
Production Capacity:- -
Main Products:Active Pharmaceutical Ingredients,Intermediates,Anti-bacterial, Anti-asthmatic, Anti-allergic, Migrane Treatment, Antibiotic,Anti-gout, Antifungal,Antidepressant,Anti-cancer, Anti-malarial, Anticonvulsant,Proton Pump Inhibitor, Antihypertensive
Address:Plot 10, Road No. 8, Film Nagar, Jubilee Hills
Main Markets:North America, South America, Eastern Europe, Sout
Location:Andhra Pradesh, India
Website:Visit website

Product

Labetalol Hydrochloride
Pregabalin
Omeprazole
Levetiracetam
Hydroxychloroquine sulfate
Bicalutamide
Amlodipine Besylate
Venlafaxine Hydrochloride
Lamotrigine
Itraconazole
Doxazosin Mesylate
Allopurinol
Aripiprazole
Paroxetine HCl
Nitrofurantoin Monohydrate
Nitrofurantoin Anhydrous
Sumatriptan Succinate
Fluvoxamine Maleate
Desloratadine
Loratadine
Montelukast Sodium
Moxifloxacin Hydrochloride
Pantoprazole Sodium
Ramipril

Category

Countries

United States All Countries